Purchases and Sales Made in Q1 2024 in Reviva Pharmaceuticals Holdings, Inc. (RVPH)
This table provides information about the institutional ownership of Reviva Pharmaceuticals Holdings, Inc. (RVPH) during Q1 2024. The information is specifically focused on institutions that hold shares of REVIVA PHARMACEUTICALS HOLDINGS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2024
Q1 2024
|
Woodline Partners LP
San Francisco, CA |
BUY
|
- |
935K+ 776.25% |
$2.58M - $5.16M
|
1.06M
$1.9M
|
|
|
May 15, 2024
Q1 2024
|
Schonfeld Strategic Advisors LLC
New York, NY |
BUY
|
- |
827KNew |
$2.28M - $4.56M
|
827K
$1.49M
|
|
|
May 15, 2024
Q1 2024
|
Parkman Healthcare Partners LLC
Stamford, CT |
BUY
|
- |
504KNew |
$1.39M - $2.78M
|
504K
$907K
|
|
|
May 15, 2024
Q1 2024
|
Polar Asset Management Partners Inc.
Toronto, A6 |
BUY
|
- |
155KNew |
$427K - $854K
|
155K
$279K
|
|
|
May 15, 2024
Q1 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
52.7K+ 6.57% |
$145K - $291K
|
855K
$1.54M
|
|
|
May 13, 2024
Q1 2024
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
41.3K+ 23.1% |
$114K - $228K
|
220K
$396K
|
|
|
Dec 26, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
38.7KNew |
$107K - $213K
|
38.7K
$69.6K
|
|
|
May 10, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
37.7K+ 4116.25% |
$104K - $208K
|
38.7K
$69.6K
|
|
|
May 07, 2024
Q1 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
37K+ 17.96% |
$102K - $204K
|
243K
$437K
|
|
|
May 10, 2024
Q1 2024
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
26.9K+ 2.75% |
$74.1K - $148K
|
1M
$1.8M
|
|
|
May 14, 2024
Q1 2024
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
10.2K+ 25.42% |
$28.2K - $56.4K
|
50.4K
$90.8K
|
|
|
May 13, 2024
Q1 2024
|
Ubs Group Ag
|
BUY
|
- |
8.1KNew |
$22.4K - $44.7K
|
8.1K
$14.6K
|
|
|
May 15, 2024
Q1 2024
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
6.94K+ 46.33% |
$19.2K - $38.3K
|
21.9K
$39.5K
|
|
|
May 15, 2024
Q1 2024
|
Jane Street Group, LLC
New York, NY |
BUY
|
- |
999+ 3.43% |
$2.76K - $5.51K
|
30.1K
$54.2K
|
|
|
Aug 16, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
BUY
|
- |
853+ 17.89% |
$2.35K - $4.71K
|
5.62K
$10.1K
|
|
|
May 15, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
BUY
|
- |
853+ 17.89% |
$2.35K - $4.71K
|
5.62K
$10.1K
|
|
|
May 10, 2024
Q1 2024
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
36+ 25.9% |
$99.4 - $199
|
175
$315
|
|
|
Apr 30, 2024
Q1 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
May 10, 2024
Q1 2024
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-377- 0.41% |
$1.04K - $2.08K
|
91.9K
$165K
|
|
|
May 13, 2024
Q1 2024
|
Wolverine Asset Management LLC
|
SELL
|
- |
-1.27K- 27.4% |
$3.52K - $7.03K
|
3.38K
$6.08K
|
|
|
May 15, 2024
Q1 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-2.3K- 3.51% |
$6.35K - $12.7K
|
63.2K
$114K
|
|
|
May 15, 2024
Q1 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-4.23K- 10.82% |
$11.7K - $23.4K
|
34.9K
$62.8K
|
|
|
Oct 17, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-12.3K- 68.64% |
$34K - $67.9K
|
5.62K
$10.1K
|
|
|
May 14, 2024
Q1 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-13.9K- 39.17% |
$38.2K - $76.5K
|
21.5K
$38.7K
|